Sign in

You're signed outSign in or to get full access.

Shawn C. Leska

Vice President of Sales at STURM RUGER & COSTURM RUGER & CO
Executive

About Shawn C. Leska

Shawn C. Leska is Vice President, Sales at Sturm, Ruger & Company, Inc., a role he has held since November 6, 2015; he joined Ruger in 1989 and previously served as Director of Sales beginning in 2011 . He is 53 years old as of the company’s FY2024 Form 10-K and serves among the executive officers listed by the Board . Leska’s remit aligns directly with revenue generation and sell-through across Ruger’s distributor and retail channels; in 2024 Ruger generated earnings before income taxes of $38.0 million, EPS of $1.77, EBITDA of $55.1 million, and cash from operations of $55.5 million, supported by $159.3 million in new product sales (32% of firearm sales) and zero debt, which underpin incentive metrics tied to EBIT and long-term RO-NOA/TSR .

Past Roles

OrganizationRoleYearsStrategic Impact
Sturm, Ruger & Company, Inc.Vice President, Sales2015–presentLeads sales strategy, distribution and sell-through across channels
Sturm, Ruger & Company, Inc.Director of Sales2011–2015Managed sales organization and key accounts, pipeline conversion
Sturm, Ruger & Company, Inc.Sales roles (various)1989–2011Progressively expanded sales responsibilities over three decades

External Roles

No external public company board roles or committee positions disclosed for Leska in the latest 10-K and Proxy .

Fixed Compensation

Multi-year cash compensation for Leska:

Metric202220232024
Base Salary ($)$316,667 $334,375 $350,000
Profit Sharing ($)$48,524 $24,490 $16,705
All Other Compensation ($)$29,934 $32,279 $33,629
Total Compensation ($)$990,292 $980,117 $1,006,867

Base salary was set at $350,000 with an effective date of August 16, 2023 .

Perquisites and benefits detail (2024):

ComponentAmount
Taxable Premiums Paid by Company for Group Term Life Insurance$2,579
Company Matching and Discretionary 401(k) Contributions$31,050

Performance Compensation

Annual Cash Incentive (2024)

Ruger’s officer bonus was tied to EBIT (80% weighting) and non-financial objectives (20%). Target EBIT was $72.4 million; actual EBIT was $39.7 million (54.8% of target). Non-financial objectives were achieved at 80% of their 20% weighting. Aggregate payout equaled 59.8% of target, yielding Leska’s actual cash award of $139,533 .

MetricWeightingTargetActualPayout (% of Target)2024 Result ($)
EBIT80% $72.4M $39.7M 54.8% of EBIT portion Included in total below
Non-Financial Objectives20% Structured set (7 objectives) 80% attainment 80% of 20% portion Included in total below
Aggregate100%59.8% $139,533

Equity Awards (2024 Grants)

Leska received both performance-based RSUs and time-based RSUs in 2024, each targeting 67% of salary. Grants were issued on February 29, 2024 at a base price of $43.25 (mean of high/low) and are determined by dividing target $ value by grant price .

Award TypeGrant DateTarget % of SalaryGrant-Date Fair Value ($)RSUs Granted (#)Vesting / Performance Metrics
Performance-Based RSUs2/29/2024 67% $233,500 5,398 3-year RO-NOA with payout 0–200%; TSR ±10% modifier
Time-Based RSUs (Retention)2/29/2024 67% $233,500 5,398 Cliff vest 100% after 3 years; settled in cash since 2020

Performance realization to date (company-wide awards): 2024 awards achieved 3% to date; 2023 awards 9%; 2022 awards 26%, indicating modest performance payout accruals so far .

Stock vested in 2024:

Vested Shares (RSUs)Value Realized Upon Vesting ($)
5,386$232,300

Equity Ownership & Alignment

Beneficial Ownership (as of April 3, 2025)

HolderShares Beneficially OwnedOptions Exercisable (≤60 days)Total Beneficial% of Class
Shawn C. Leska38,820 38,820 * (<1%)

Stock ownership guidelines require two times base salary for other Named Executive Officers (NEOs), which includes the VP Sales role; CEO 5×, SVPs 3× . The Insider Trading Policy prohibits hedging and speculative transactions; the Executive Compensation Clawback Policy allows clawbacks for restatements tied to securities law noncompliance .

Unvested RSUs Outstanding (12/31/2024)

Grant CohortGrant-Date Fair Value ($)Units Not Vested (#)Market Value at $35.37 Close ($)
2024 Retention RSUs$233,500 5,398 $190,927
2024 Performance RSUs$233,500 5,398 $190,927
2023 RSUs (combined rows)$216,800 4,087 $144,557
2022 RSUs (combined rows)$201,000 2,813 $99,496

Hedging prohibited; no pledging disclosures were noted in the filings .

Employment Terms

Severance & Change-of-Control (Leska – executed November 25, 2024)

  • Pre-Change-in-Control termination (Company w/o Cause or Officer for Good Reason): lump sum equal to 18 months of Base Annual Salary, pro-rated vesting of outstanding Retention and Performance RSUs, and continuation of medical insurance benefits up to 18 months, subject to executing a Release .
  • Post-Change-in-Control termination within 24 months (Company w/o Cause or Officer for Good Reason): lump sum equal to 24 months of Annual Compensation (Base Salary + target cash bonus), full vesting of Retention and Performance RSUs paid in a lump sum equal to the cash value as of the effective date of the Change in Control, and continuation of medical insurance benefits up to 24 months, subject to Release .
  • Agreement term: one year with automatic annual extensions unless the Company gives written notice ≥360 days prior or the officer gives notice/terminates before renewal; includes a Section 280G excise tax cutback and Section 409A compliance provisions .
  • Non-compete and non-solicit obligations are embedded in the general Release during the severance period; confidentiality applies during and after the severance period; Colorado carve-outs apply per statute .

Change-in-control vesting mechanics under stock plans:

  • 2017 Plan: potential accelerated vesting unless assumed/substituted in a merger; some awards require double-trigger .
  • 2023 Plan: double-trigger accelerated vesting only if termination without cause or for good reason following a change in control and awards are assumed/substituted/continued .

Potential Payments (Illustrative table, company-disclosed estimates at 12/31/2024)

ScenarioSeverance Payment ($)Performance-Based Cash (Nominal @ 200%) ($)Equity Awards That Vest (#)Medical Continuation ($)Aggregate Payments ($)
Change in Control Termination$700,000 $466,700 22,402 $32,900 $1,199,600
Termination w/o Cause (pre-CIC)$525,000 $0 6,449 $32,900 $557,900
Retirementn/a $233,300 $0 $233,300
Death or Disabilityn/a $233,300 24,956 $0 $233,300

Notes: Performance payouts under retirement/death/disability are prorated to the extent earned; aggregate excludes RSU counts for vesting .

Investment Implications

  • Pay-for-performance alignment: 2024 officer bonus paid at 59.8% of target driven by below-target EBIT, and multi-year RO-NOA/TSR conditions have low realized achievement to date (2024: 3%; 2023: 9%; 2022: 26%), signaling disciplined equity payouts tied to operating performance and market returns .
  • Retention vs. selling pressure: Three-year cliff vesting retention RSUs and ongoing performance RSUs create staggered vesting through 2025–2027, which supports retention but can create periodic liquidity events upon vesting; 2024 vesting realized $232,300 for Leska on 5,386 shares .
  • Change-in-control protection: 18-month/24-month cash severance multiples plus RSU acceleration (pro-rata pre-CIC; full post-CIC) and medical continuation provide meaningful retention during corporate transitions; non-compete/non-solicit obligations during the severance period reduce immediate competitive risk .
  • Alignment safeguards: Stock ownership guidelines (2× base for NEOs), formal clawback, and prohibitions on hedging/speculative trading reinforce long-term equity alignment, with strong shareholder support for pay practices (97% Say-on-Pay approval in 2024) .

Appendix: Company Performance Context (2024)

Metric2024
Earnings Before Income Taxes ($)$38.0M
EPS ($)$1.77
EBITDA ($)$55.1M
Cash From Operations ($)$55.5M
New Product Sales ($)$159.3M (32% of firearm sales)
Ending Cash & Short-Term Investments ($)$105.5M; Debt: $0

Governance and compensation program features (selection): Independent Compensation Committee oversight and use of consultants; equity grants set after public filings; re-pricing prohibited; RSUs used instead of options; insider trading, hedging prohibitions; clawback policy .